Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Less than $10/month! View ALL results for your Stocks, ETFs and Funds Screeners with Barchart Plus. FREE 30 Day Trial
Stocks | Futures | Watchlist | More
or

GT Biopharma Inc (GTBP)

GT Biopharma Inc (GTBP)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Profile for [[ item.sessionDateDisplayLong ]]

Company Info

GT Biopharma Inc 8000 MARINA BLVD BRISBANE CA 94005 USA

www.gtbiopharma.com P: 415-919-4040

Description:

GT Biopharma Inc. is an immuno-oncology company. It discovers, develops and commercializes drugs of therapeutic molecules for the treatment of cancer, myeloma, osteolytic lesions and other unmet medical needs. GT Biopharma Inc., formerly known as OXIS International Inc., is based in Tampa, Florida.

Key Statistics

Overview:

Market Capitalization, $K 6,386
Enterprise Value, $K 716
Shares Outstanding, K 1,379
Annual Sales, $ 0 K
Annual Net Income, $ -20,880 K
Last Quarter Sales, $ 0 K
Last Quarter Net Income, $ -2,420 K
EBIT, $ -16,190 K
EBITDA, $ -16,190 K
60-Month Beta 0.57
% of Insider Shareholders 10.00%
% of Institutional Shareholders 8.15%
Float, K 1,241
% Float 90.00%
Short Volume Ratio 0.52

Growth:

1-Year Return -72.27%
3-Year Return -97.83%
5-Year Return -97.46%
5-Year Revenue Growth 0.00%
5-Year Earnings Growth 99.55%
5-Year Dividend Growth 0.00%

Per-Share Information:

Most Recent Earnings -1.80 on 11/01/23
Latest Earnings Date 04/04/24
Earnings Per Share ttm -12.31
EPS Growth vs. Prev Qtr 33.33%
EPS Growth vs. Prev Year 72.73%
Annual Dividend Yield 0.00%
Dividend Payout Ratio 0.00%
Most Recent Split 1-30 on 02/05/24

GTBP Ratios

Ratio
Price/Earnings ttm 0.00
Price/Earnings forward N/A
Price/Earnings to Growth N/A
Return-on-Equity % -125.05%
Return-on-Assets % -81.86%
Profit Margin % 0.00%
Debt/Equity 0.00
Price/Sales N/A
Price/Cash Flow N/A
Price/Book 0.64
Book Value/Share 7.41
Interest Coverage -2,087.00
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar